pe
pep-04983 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (ANSSIL)

A small peptide that blocks an enzyme the body uses to raise blood pressure; studied as a possible blood-pressure treatment, experimental, not yet an approved drug.

statuscomputed targetACE length6 aa refs3
anti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.796
pTM0.632
avg pLDDT91.1
ranking score0.888
STRUCTURE · PEP-04983 × ACE
ranking0.888
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence6 aa
156
ANSSIL
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7964335680007935 boltz-2
ranking score 0.8882977366447449 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.863global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Ala-Asn-Ser-Ser-Ile-Leu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (ANSSIL) (pep-04983, v1). PeptideModel. https://peptidemodel.com/card/pep-04983
@peptide{pep04983,
  sequence = {ANSSIL},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use